adrenaline (epinephrine) acid tartrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial AUST R: 12008Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride
Dosage form: Injection, solution
Sponsor: Aspen Pharmacare Australia Pty Ltd
Phone: 1300659646
|
From 22 Dec 2021 to 31 Dec 2024
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: Other strengths available.
|
XYLOCAINE 2% WITH ADRENALINE 1:200,000 20mL injection vial AUST R: 12021Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride
Dosage form: Injection, solution
Sponsor: Aspen Pharmacare Australia Pty Ltd
Phone: 1300659646
|
From 19 Oct 2023 to 01 Jun 2024
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: An unregistered product has been approved for supply under Section 19A.The approval holder, Reach Pharmaceuticals can be contacted for details on supply on: 0422 429 648
|
SEPTANEST 1:200,000 articaine HCl 4% with adrenaline 1:200,000 solution for injection 2.2 mL cartridge AUST R: 271232Active ingredients:
adrenaline (epinephrine) acid tartrate
articaine hydrochloride
Dosage form: Injection, solution
Sponsor: Specialites Septodont Pty Ltd
Phone: 0432292770
|
From 13 Nov 2023 to 10 Mar 2024
|
Shortage status: Resolved
Availability: Available
Reason: Unexpected increase in demand due to other sponsors unable to supply
|